Pregahike DM 75/30 Capsule contains Pregabalin 75mg + Methylcobalamin 1500mcg + Duloxetine 30mg, a triple-action therapy for effective management of neuropathic pain, nerve damage, and chronic pain conditions. Pregabalin reduces abnormal nerve signals, Methylcobalamin promotes nerve regeneration and repair, and Duloxetine enhances central pain modulation, ensuring complete nerve support.
This combination provides superior therapeutic benefits and is highly trusted by prescribers, generating consistent demand. Its multi-target approach allows patients to experience improved pain relief and nerve health with better adherence to treatment plans.
For franchise partners, Pregahike DM 75/30 Capsule is a high-demand neurological therapy product with excellent market acceptance. Its clinical efficacy, patient compliance, and prescriber confidence make it a profitable addition to neurology portfolios, helping expand business opportunities and attract loyal customers.
With its combination of pain relief and nerve repair, Pregahike DM 75/30 Capsule supports sustainable sales growth, making it an ideal choice for partners targeting neurology and chronic pain markets.